1. Home
  2. ZURA vs KEQU Comparison

ZURA vs KEQU Comparison

Compare ZURA & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • KEQU
  • Stock Information
  • Founded
  • ZURA 2022
  • KEQU 1906
  • Country
  • ZURA United States
  • KEQU United States
  • Employees
  • ZURA N/A
  • KEQU N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • KEQU Medical Specialities
  • Sector
  • ZURA Health Care
  • KEQU Industrials
  • Exchange
  • ZURA Nasdaq
  • KEQU Nasdaq
  • Market Cap
  • ZURA 137.2M
  • KEQU 124.6M
  • IPO Year
  • ZURA N/A
  • KEQU N/A
  • Fundamental
  • Price
  • ZURA $3.34
  • KEQU $45.70
  • Analyst Decision
  • ZURA Buy
  • KEQU
  • Analyst Count
  • ZURA 9
  • KEQU 0
  • Target Price
  • ZURA $11.00
  • KEQU N/A
  • AVG Volume (30 Days)
  • ZURA 4.3M
  • KEQU 10.9K
  • Earning Date
  • ZURA 11-06-2025
  • KEQU 12-10-2025
  • Dividend Yield
  • ZURA N/A
  • KEQU N/A
  • EPS Growth
  • ZURA N/A
  • KEQU N/A
  • EPS
  • ZURA N/A
  • KEQU 4.13
  • Revenue
  • ZURA N/A
  • KEQU $263,183,000.00
  • Revenue This Year
  • ZURA N/A
  • KEQU N/A
  • Revenue Next Year
  • ZURA N/A
  • KEQU N/A
  • P/E Ratio
  • ZURA N/A
  • KEQU $11.15
  • Revenue Growth
  • ZURA N/A
  • KEQU 30.09
  • 52 Week Low
  • ZURA $0.97
  • KEQU $30.33
  • 52 Week High
  • ZURA $4.96
  • KEQU $71.33
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 55.62
  • KEQU 48.76
  • Support Level
  • ZURA $3.18
  • KEQU $41.32
  • Resistance Level
  • ZURA $3.51
  • KEQU $46.50
  • Average True Range (ATR)
  • ZURA 0.36
  • KEQU 1.57
  • MACD
  • ZURA -0.08
  • KEQU 0.74
  • Stochastic Oscillator
  • ZURA 50.40
  • KEQU 84.56

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Share on Social Networks: